Literature DB >> 22594115

Correlative analysis of neoplasm patients with phlegm-stasis or abnormal Savda syndrome, based on metabonomics.

Mamtimin Batur1, Upur Halmurat, Fu-Hua Hao, Rena Aiziz, Matsidik Aynur.   

Abstract

OBJECTIVE: To investigate plasma samples from neoplasm patients with phlegm-stasis or abnormal Savda syndrome, with NMR spectroscopy, and to analyze their metabolic varieties, characteristics and reciprocity.
METHODS: 1H-NMR spectra were analyzed using the orthogonal projection to latent structure with discriminative analysis (OPLS-DA) method with unit variance scaling. The discriminative significance of metabolites was determined by the Pearson's product - moment correlation coefficient.
RESULTS: Compared to the control group, neoplasm patients with phlegm - stasis or abnormal Savda syndrome had low concentrations of leucine, isoleucine, valine, alanine, tyrosine, histidine, citrulline, glycoprotein, glutamine, myo-inositol, scyllo-inositol, creatine, alpha-glucose, alpha-glucose and lactate (P < 0.05), and high concentrations of very low density lipoprotein, low density lipoprotein, unsaturated lipid, formate, acetone, acetate, acetoacetate, pyruvate, beta-hydroxybutyrate, carnitine and malonic acid (P < 0.05), with no significant differences between the phlegm - stasis and abnormal Savda syndrome patients.
CONCLUSIONS: Neoplasm patients with different syndromes have very similar metabolic changes. A series of abnormalities such as immune dysfunction and oxidative - antioxidative imbalance, occur in neoplasm patients with abnormal Savda or phlegm - stasis syndrome.

Entities:  

Mesh:

Year:  2012        PMID: 22594115     DOI: 10.1016/s0254-6272(12)60044-2

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  6 in total

1.  Plasma metabonomics study of the patients with acute anterior uveitis based on ultra-performance liquid chromatography-mass spectrometry.

Authors:  Junguo Guo; Tingqin Yan; Hongsheng Bi; Xiaofeng Xie; Xingrong Wang; Dadong Guo; Haiqiang Jiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-08       Impact factor: 3.117

2.  Clinical characteristics of abnormal savda syndrome type in human immunodeficiency virus infection and acquired immune deficiency syndrome patients: A cross-sectional investigation in Xinjiang, China.

Authors:  Mi-ji-ti Peierdun; Wen-xian Liu; Ai-ze-zi Renaguli; Amat Nurmuhammat; Xiao-chun Li; Ka-ha-er Gulibaier; Wu-la-mu Ainivaer; Upur Halmurat
Journal:  Chin J Integr Med       Date:  2015-03-06       Impact factor: 2.626

3.  Identification of plasma protein markers common to patients with malignant tumour and Abnormal Savda in Uighur medicine: a prospective clinical study.

Authors:  Halmurat Upur; Yin Chen; Mayila Kamilijiang; Wanli Deng; Xierzhatijiang Sulaiman; Renaguli Aizezi; Xiao Wu; Wuniqiemu Tulake; Abulizi Abudula
Journal:  BMC Complement Altern Med       Date:  2015-02-05       Impact factor: 3.659

4.  Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics.

Authors:  Batur Mamtimin; Guo Xia; Mahmut Mijit; Mawlanjan Hizbulla; Nazuk Kurbantay; Li You; Halmurat Upur
Journal:  Pharmacogn Mag       Date:  2015 Oct-Dec       Impact factor: 1.085

Review 5.  Recent Advances and Perspective of Studies on Phlegm Syndrome in Chinese Medicine.

Authors:  Zhiguo Zhang; Jingqing Hu
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-14       Impact factor: 2.629

6.  Differential integrative omic analysis for mechanism insights and biomarker discovery of abnormal Savda syndrome and its unique Munziq prescription.

Authors:  Xia Guo; Iskandar Bakri; Abulizi Abudula; Kalbinur Arken; Mahmut Mijit; Batur Mamtimin; Halmurat Upur
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.